Ohm Laboratories Inc
General
Total Cases12
Active Cases--
Patents183
Ratings
Experience
Grade
Trend
DCT
L5
E
PTAB
L5
A
CAFC
L4
C
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 10/04/23 | Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 10/4/2023. (Court Reporter Stacy Ingram (302)658-6697.) (nmf) (Entered: 10/04/2023) | |
| 10/02/23 | ORAL ORDER re 482 Status Report. ORDER Setting Teleconference: Counsel for Defendants to coordinate the call and email the dial-in information to chambers. (A Telephone Conference is set for 10/4/2023 at 04:00 PM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 10/2/2023. (nmf) (Entered: 10/02/2023) | |
| 09/12/23 | SO ORDERED, re 483 Proposed Consent Judgment. Party InvaGen Pharmaceuticals, Inc., Cipla Limited and Cipla USA, Inc. terminated. Signed by Judge Colm F. Connolly on 9/12/2023. (nmf) (Entered: 09/12/2023) | |
| 09/06/23 | PROPOSED CONSENT JUDGMENT as to Defendants Cipla Limited, Cipla USA, Inc. and InvaGen Pharmaceuticals, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 09/06/2023) | |
| 07/28/23 | Joint STATUS REPORT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/28/2023) | |
| 06/13/23 | SO ORDERED, re 480 STIPULATION TO EXTEND TIME for Defendants to conduct a Rule 30(b)(6) deposition and for the parties to file a joint status report to July 24, 2023 and July 28, 2023, respectively, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Resetting Deadlines: Status Report due by 7/28/2023. Signed by Judge Colm F. Connolly on 6/13/2023. (kmd) (Entered: 06/13/2023) | |
| 06/09/23 | STIPULATION TO EXTEND TIME for Defendants to conduct a Rule 30(b)(6) deposition and for the parties to file a joint status report to July 24, 2023 and July 28, 2023, respectively - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 06/09/2023) | |
| 05/19/23 | CONSENT JUDGMENT as to Laurus Labs Ltd. and Laurus Generics, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Party Laurus Generics Inc. and Laurus Labs Ltd. terminated. Signed by Judge Colm F. Connolly on 5/18/2023. (nmf) (Entered: 05/19/2023) | |
| 05/18/23 | CONSENT JUDGMENT as to Laurus Labs Ltd. and Laurus Generics, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Party Laurus Labs Ltd. and Laurus Generics Inc. terminated. Signed by Judge Colm F. Connolly on 5/18/2023. (nmf) (Entered: 05/18/2023) | |
| 05/17/23 | PROPOSED CONSENT JUDGMENT as to Laurus Labs Ltd. and Laurus Generics, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 05/17/2023) |